https://www.aexcea.com/msacl-biohorizon-2026-conferences/ 2026-10-04T16:28:40+00:00 https://www.aexcea.com/biomark-diagnostics-to-present-liquid-biopsy-platform-at-the-canadian-thoracic-society-research-forum/ 2026-09-24T20:35:25+00:00 https://www.aexcea.com/new-scientific-advisory-board/ 2026-09-24T19:40:41+00:00 https://www.aexcea.com/commercialization-and-prototype-development/ 2026-09-24T19:40:40+00:00 https://www.aexcea.com/scientific-presentations-and-publications/ 2026-09-24T19:40:39+00:00 https://www.aexcea.com/clinical-trials-multi-site/ 2026-09-24T19:40:37+00:00 https://www.aexcea.com/new-discovery/ 2026-09-24T19:40:37+00:00 https://www.aexcea.com/collaboration-and-mitacs-support/ 2026-09-24T19:40:36+00:00 https://www.aexcea.com/key-milestones-achieved-in-2013-2h-second-half/ 2026-09-24T19:40:35+00:00 https://www.aexcea.com/biomark-and-going-global-spring-2013/ 2026-09-24T19:40:34+00:00 https://www.aexcea.com/biomark-is-proud-to-announce/ 2026-09-24T19:40:33+00:00 https://www.aexcea.com/biomark-news-summary-2007-2012/ 2026-09-24T19:40:32+00:00 https://www.aexcea.com/wp-content/uploads/2014/07/tumor.png https://www.aexcea.com/wp-content/uploads/2014/07/team.png https://www.aexcea.com/wp-content/uploads/2014/07/university-of-victoria.png https://www.aexcea.com/wp-content/uploads/2014/07/british.png https://www.aexcea.com/wp-content/uploads/2014/07/Brian-Cheng-and-Rashid-Ahmed.png https://www.aexcea.com/wp-content/uploads/2014/07/Dr.-B.-Ramjiawan-.png https://www.aexcea.com/wp-content/uploads/2014/07/Dr.-Daniel-Sitar-B.Sc_.-Ph.D.-.png https://www.aexcea.com/wp-content/uploads/2014/07/Hon.-Minister-Ida-Chona-.png https://www.aexcea.com/wp-content/uploads/2014/07/Minister-Ida-Chona-.png https://www.aexcea.com/wp-content/uploads/2014/07/Dave-Hayer-.png https://www.aexcea.com/wp-content/uploads/2014/07/Kenyan-High-Commissioner-.png https://www.aexcea.com/wp-content/uploads/2014/07/Canadian-Manufacturers.png https://www.aexcea.com/wp-content/uploads/2014/07/certificates.png https://www.aexcea.com/wp-content/uploads/2014/07/awards.png https://www.aexcea.com/wp-content/uploads/2014/07/chaina-1.png https://www.aexcea.com/wp-content/uploads/2014/07/chaina-2.png https://www.aexcea.com/wp-content/uploads/2014/07/chaina-3.png https://www.aexcea.com/wp-content/uploads/2014/07/chaina-4.png https://www.aexcea.com/wp-content/uploads/2014/07/columbia.png https://www.aexcea.com/wp-content/uploads/2014/07/detection-1.png https://www.aexcea.com/wp-content/uploads/2014/07/detection-2.png https://www.aexcea.com/wp-content/uploads/2014/07/detection-3.png https://www.aexcea.com/wp-content/uploads/2014/07/Rashid-Ahmed-Other.png https://www.aexcea.com/wp-content/uploads/2014/07/tigermed.png https://www.aexcea.com/wp-content/uploads/2014/07/manitoba.png https://www.aexcea.com/wp-content/uploads/2014/07/CIL.png https://www.aexcea.com/wp-content/uploads/2014/07/bmc.png https://www.aexcea.com/wp-content/uploads/2014/07/manitoba.png https://www.aexcea.com/new-corporate-alliances/ 2026-09-24T19:40:31+00:00 https://www.aexcea.com/trace-cancer-biomarker-quantification-using-polystyrene-functionalized-gold-nanorods/ 2026-09-24T19:40:30+00:00 https://www.aexcea.com/biomark-raman-sensers-product-launch-at-strategies-on-biophotonics-boston/ 2026-09-24T19:40:29+00:00 https://www.aexcea.com/biomark-raman-sensers-product-launch/ 2026-09-24T19:40:28+00:00 https://www.aexcea.com/wp-content/uploads/2014/09/IPS-and-Jim_sm.jpg https://www.aexcea.com/biomark-selected-for-one-of-the-25-spots-at-hub-in-boston/ 2026-09-24T19:40:27+00:00 https://www.aexcea.com/lung-cancer-news-today-new-urine-test-offers-early-lung-cancer-detection/ 2026-09-24T19:40:26+00:00 https://www.aexcea.com/bbc-news-health-call-for-lung-cancer-screening-in-uk/ 2026-09-24T19:40:25+00:00 https://www.aexcea.com/sun-news-lung-cancer-deadliest-in-n-america/ 2026-09-24T19:40:24+00:00 https://www.aexcea.com/wp-content/uploads/2014/09/Screen-shot-2014-09-18-at-10.40.31-AM.png https://www.aexcea.com/wp-content/uploads/2014/09/Screen-shot-2014-09-18-at-10.39.29-AM.png https://www.aexcea.com/wp-content/uploads/2014/09/Screen-shot-2014-09-18-at-10.38.44-AM.png https://www.aexcea.com/wp-content/uploads/2014/09/Screen-shot-2014-09-18-at-10.37.22-AM.png https://www.aexcea.com/biomark-expands-phase-3-clinical-trials/ 2026-09-24T19:40:23+00:00 https://www.aexcea.com/biomark-approved-listing-and-commences-trading-on-the-cse/ 2026-09-24T19:40:22+00:00 https://www.aexcea.com/biomark-announces-appointment-of-bill-good/ 2026-09-24T19:40:21+00:00 https://www.aexcea.com/biomark-diagnostics-inc-to-present-at-the-inaugural-equities-com-small-cap-stars-conference-at-the-nasdaq-marketsite-on-december-18-2014/ 2026-09-24T19:40:20+00:00 https://www.aexcea.com/dr-john-yoo-joins-biomark-advisory-team-2/ 2026-09-24T19:40:19+00:00 https://www.aexcea.com/dr-john-yoo-joins-biomark-advisory-team/ 2026-09-24T19:40:18+00:00 https://www.aexcea.com/biomark-receives-the-commercialization-support-for-business-csb-stream-1-program/ 2026-09-24T19:40:17+00:00 https://www.aexcea.com/biomark-lists-on-frankfurt-stock-exchange/ 2026-09-24T19:40:16+00:00 https://www.aexcea.com/wolverton-securities-advisor-believes-in-biotechnology/ 2026-09-24T19:40:15+00:00 https://www.aexcea.com/dr-safieddin-safavi-naeini-joins-biomark-scientific-advisory-team/ 2026-09-24T19:40:15+00:00 https://www.aexcea.com/biomark-records-first-revenues/ 2026-09-24T19:40:14+00:00 https://www.aexcea.com/biomark-receives-health-canada-protocol-approval/ 2026-09-24T19:40:13+00:00 https://www.aexcea.com/biomark-diagnostics-develops-cancer-diagnostics-kit/ 2026-09-24T19:40:12+00:00 https://www.aexcea.com/wp-content/uploads/2014/12/CanadianInvestor1-300x54.jpg https://www.aexcea.com/biomark-diagnostics-at-the-equities-com-small-cap-stars-conference-at-the-nasdaq-marketsite/ 2026-09-24T19:40:11+00:00 https://www.aexcea.com/biomark-announces-a-partial-closing-private-placement/ 2026-09-24T19:40:10+00:00 https://www.aexcea.com/global-news-richmond-company-develops-urine-cancer-test/ 2026-09-24T19:40:09+00:00 https://www.aexcea.com/biomark-receives-us-trading-symbol-bmkdf-from-finra-and-commences-trading-in-the-usa/ 2026-09-24T19:40:08+00:00 https://www.aexcea.com/biomark-to-be-on-cbc-early-edition/ 2026-09-24T19:40:07+00:00 https://www.aexcea.com/biomark-cbc-radio-interview/ 2026-09-24T19:40:07+00:00 https://www.aexcea.com/cambridges-2015-vancouver-resource-investment-conference-in-a-nutshell/ 2026-09-24T19:40:06+00:00 https://www.aexcea.com/equities-com-interview-with-rashid-ahmed-ceo/ 2026-09-24T19:40:05+00:00 https://www.aexcea.com/biomark-brings-new-life-to-cancer-detection-technology/ 2026-09-24T19:40:04+00:00 https://www.aexcea.com/biomark-attends-photonics-west-california/ 2026-09-24T19:40:03+00:00 https://www.aexcea.com/biomark-announces-otcqb-listing/ 2026-09-24T19:40:02+00:00 https://www.aexcea.com/biomark-announces-a-final-closing-private-placement/ 2026-09-24T19:40:01+00:00 https://www.aexcea.com/uvic-research-discovers-a-promising-new-way-to-detect-lung-cancer/ 2026-09-24T19:40:00+00:00 https://www.aexcea.com/criterion-bioscience-provides-the-coverage-on-biomark-diagnostics-inc-in-usa/ 2026-09-24T19:39:59+00:00 https://www.aexcea.com/wp-content/uploads/2015/02/CriterionBioScience-300x62.jpg https://www.aexcea.com/wp-content/uploads/2015/02/Screen-shot-2015-02-23-at-10.19.03-PM.png https://www.aexcea.com/biomark-announces-grant-funded-partnership-with-tmic/ 2026-09-24T19:39:58+00:00 https://www.aexcea.com/biomark-added-to-cse-composite-index/ 2026-09-24T19:39:57+00:00 https://www.aexcea.com/biomark-announces-partnership-with-the-metabolomics-innovation-centre/ 2026-09-24T19:39:56+00:00 https://www.aexcea.com/biomark-receives-biap-funding-from-nrc-irap/ 2026-09-24T19:39:55+00:00 https://www.aexcea.com/biomark-receives-nserc-engage-grant-for-raman-enhancement-with-dr-safieddin-safavi-naeini/ 2026-09-24T19:39:54+00:00 https://www.aexcea.com/florida-cancer-specialists-foundation-havana-night/ 2026-09-24T19:39:53+00:00 https://www.aexcea.com/biomark-presents-at-11th-annual-conference-of-the-metabolomics-society/ 2026-09-24T19:39:52+00:00 https://www.aexcea.com/biomarks-clinical-technology-center-at-innovation-boulevard-in-surrey-bc/ 2026-09-24T19:39:51+00:00 https://www.aexcea.com/biomark-and-response-to-treatment/ 2026-09-24T19:39:50+00:00 https://www.aexcea.com/wp-content/uploads/2015/05/WCIO_logos.jpg https://www.aexcea.com/biomark-receives-no-objection-letter-from-health-canada/ 2026-09-24T19:39:49+00:00 https://www.aexcea.com/cancer-cases-projected-to-rise-40-in-15-years-as-population-ages-grows/ 2026-09-24T19:39:48+00:00 https://www.aexcea.com/biomark-secures-dtc-eligibility/ 2026-09-24T19:39:47+00:00 https://www.aexcea.com/new-cancer-strategy-could-save-thousands-of-lives/ 2026-09-24T19:39:46+00:00 https://www.aexcea.com/biomark-diagnostics-sponsored-project-receives-nserc-engage-grant/ 2026-09-24T19:39:45+00:00 https://www.aexcea.com/biomark-diagnostics-engages-lha-for-investors-relations/ 2026-09-24T19:39:44+00:00 https://www.aexcea.com/biomark-appoints-dr-thomas-malcolm-to-lead-u-s-operations/ 2026-09-24T19:39:43+00:00 https://www.aexcea.com/biomark-diagnostics-unveils-u-s-strategy/ 2026-09-24T19:39:42+00:00 https://www.aexcea.com/biomark-diagnostics-to-open-u-s-headquarters-in-maryland/ 2026-09-24T19:39:40+00:00 https://www.aexcea.com/wp-content/uploads/2015/08/BioMaryland.png https://www.aexcea.com/biomark-diagnostics-announces-progress-in-assay-validation-for-clinical-sample-analysis/ 2026-09-24T19:39:39+00:00 https://www.aexcea.com/biomark-diagnostics-receives-clearance-from-health-canada-to-commence-clinical-trial-with-patented-non-invasive-urine-based-assay-to-measure-response-to-treatment-for-lung-cancer/ 2026-09-24T19:39:38+00:00 https://www.aexcea.com/quest-for-game-changing-lung-cancer-diagnostic-assay/ 2026-09-24T19:39:37+00:00 https://www.aexcea.com/biomark-diagnostics-to-conduct-validation-studies-for-its-patented-assays-in-patients-with-lung-cancerdr-james-bond-of-surrey-memorial-hospital-to-act-as-principal-investigator/ 2026-09-24T19:39:36+00:00 https://www.aexcea.com/biomark-diagnostics-to-conduct-validation-studies-for-its-patented-assays-in-patients-with-lung-cancer-dr-james-bond-of-surrey-memorial-hospital-to-act-as-principal-investigator/ 2026-09-24T19:39:35+00:00 https://www.aexcea.com/biomark-agm/ 2026-09-24T19:39:34+00:00 https://www.aexcea.com/biomark-diagnostics-presents-at-rodman-renshaw-conference-in-ny-usa/ 2026-09-24T19:39:33+00:00 https://www.aexcea.com/biomark-ceo-interview-with-snnlive-sep-2015/ 2026-09-24T19:39:31+00:00 https://www.aexcea.com/biomark-announces-progress-towards-data-analysis/ 2026-09-24T19:39:30+00:00 https://www.aexcea.com/dr-james-bond-on-biomark/ 2026-09-24T19:39:29+00:00 https://www.aexcea.com/world-cancer-day-message-of-hope/ 2026-09-24T19:39:28+00:00 https://www.aexcea.com/a-good-choice-for-mmj-and-biotech-market-opportunity/ 2026-09-24T19:39:27+00:00 https://www.aexcea.com/wp-content/uploads/2016/03/gaalen-engen-stockhouse-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2016/03/bill-good-stockhouse-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2016/03/bill-good-article-biomark-logo.png https://www.aexcea.com/wp-content/uploads/2016/03/stockhouse-biomark-graphic.jpg https://www.aexcea.com/wp-content/uploads/2016/03/vodis-pharmacueticals.png https://www.aexcea.com/biomark-closes-first-tranche-of-private-placement-offering/ 2026-09-24T19:39:26+00:00 https://www.aexcea.com/biomark-receives-approval-for-its-lung-cancer-treatment-protocol/ 2026-09-24T19:39:25+00:00 https://www.aexcea.com/biomark-closes-second-tranche-of-private-placement-offering/ 2026-09-24T19:39:24+00:00 https://www.aexcea.com/biomark-engages-stockhouse-com-deal-room-with-private-placement/ 2026-09-24T19:39:23+00:00 https://www.aexcea.com/stockhouse-com-and-biomark-interview-about-early-cancer-detection-podcast/ 2026-09-24T19:39:22+00:00 https://www.aexcea.com/biomark-closes-second-tranche-of-private-placement-offering-2/ 2026-09-24T19:39:21+00:00 https://www.aexcea.com/biomark-completes-data-collection-and-submits-data-for-analysis-prior-to-health-canada-submission/ 2026-09-24T19:39:19+00:00 https://www.aexcea.com/a-supramolecular-indicator-displacement-assay-for-acetyl-amantadine/ 2026-09-24T19:39:18+00:00 https://www.aexcea.com/biomark-invited-to-project-pitch-stage-for-gapp-application/ 2026-09-24T19:39:17+00:00 https://www.aexcea.com/biomark-selected-to-pitch-at-2017-bctech-summit/ 2026-09-24T19:39:16+00:00 https://www.aexcea.com/biomark-closes-previous-announced-private-placement-offering/ 2026-09-24T19:39:15+00:00 https://www.aexcea.com/biomark-announces-private-placement-offering/ 2026-09-24T19:39:14+00:00 https://www.aexcea.com/biomark-appoints-ms-guoyu-huang-as-interim-cfo/ 2026-09-24T19:39:13+00:00 https://www.aexcea.com/biomark-closes-first-tranche-of-over-subscribed-private-placement-offering/ 2026-09-24T19:39:12+00:00 https://www.aexcea.com/biomark-announces-multiple-patents-issued/ 2026-09-24T19:39:11+00:00 https://www.aexcea.com/biomark-announces-appointment-of-scientific-and-medical-advisors/ 2026-09-24T19:39:10+00:00 https://www.aexcea.com/biomark-announces-patent-granted-in-china/ 2026-09-24T19:39:09+00:00 https://www.aexcea.com/biomarks-clinical-trial-research-update/ 2026-09-24T19:39:08+00:00 https://www.aexcea.com/dr-ian-smith-joins-biomarks-board-of-directors/ 2026-09-24T19:39:07+00:00 https://www.aexcea.com/global-affairs-canada-supports-biomarks-trip-to-japan/ 2026-09-24T19:39:06+00:00 https://www.aexcea.com/further-progress-in-biomarks-clinical-trial-and-regulatory-review/ 2026-09-24T19:39:05+00:00 https://www.aexcea.com/ai-early-diagnosis-could-save-heart-and-cancer-patients/ 2026-09-24T19:39:04+00:00 https://www.aexcea.com/biomarks-health-canada-submission-update/ 2026-09-24T19:39:03+00:00 https://www.aexcea.com/biomark-diagnostics-sponsored-project-receives-nserc-engage-grant-2/ 2026-09-24T19:39:02+00:00 https://www.aexcea.com/biomark-partners-with-alberta-machine-intelligence-institute-to-amplify-clinical-diagnostic-decision-making/ 2026-09-24T19:39:00+00:00 https://www.aexcea.com/dr-paramjit-tappia-joins-biomark-scientific-advisory-team/ 2026-09-24T19:38:59+00:00 https://www.aexcea.com/biomark-contributes-in-scientific-publication/ 2026-09-24T19:38:58+00:00 https://www.aexcea.com/dr-sandeep-singhal-joins-biomaark-scientific-advisory-team/ 2026-09-24T19:38:58+00:00 https://www.aexcea.com/biomark-closes-final-tranche-of-private-placement-offering/ 2026-09-24T19:38:57+00:00 https://www.aexcea.com/dr-myron-weisfedlt-joins-biomarks-scientific-advisory-team/ 2026-09-24T19:38:56+00:00 https://www.aexcea.com/biomark-announces-new-patent-granted-in-china/ 2026-09-24T19:38:55+00:00 https://www.aexcea.com/biomark-contributes-additional-scientific-publication/ 2026-09-24T19:38:54+00:00 https://www.aexcea.com/opportunities-and-challenges-for-lung-cancer-screening-in-china/ 2026-09-24T19:38:53+00:00 https://www.aexcea.com/lung-cancer-screening-in-real-world-has-high-false-positive-rate/ 2026-09-24T19:38:52+00:00 https://www.aexcea.com/wp-content/uploads/2021/05/medical-tubes-with-colorful-fluids-P2XQ7DJ.jpg https://www.aexcea.com/about-glioblastoma-gbm/ 2026-09-24T19:38:52+00:00 https://www.aexcea.com/wp-content/uploads/2021/05/magnetic-resonance-imaging-PR8UWRY.jpg https://www.aexcea.com/cancer-risk-in-families/ 2026-09-24T19:38:50+00:00 https://www.aexcea.com/wp-content/uploads/2021/05/pregnant-wife-suffering-from-cancer-PGAK7B5.jpg https://www.aexcea.com/biomarks-abstract-accepted-for-2019-asco-online-publication/ 2026-09-24T19:38:49+00:00 https://www.aexcea.com/biomark-and-its-team-of-collaborators-secure-chrp-funding/ 2026-09-24T19:38:48+00:00 https://www.aexcea.com/biomark-announces-the-private-placement/ 2026-09-24T19:38:47+00:00 https://www.aexcea.com/biomark-closes-the-private-placement-offering/ 2026-09-24T19:38:47+00:00 https://www.aexcea.com/biomarks-abstract-for-2019-asco-online-publication/ 2026-09-24T19:38:45+00:00 https://www.aexcea.com/wp-content/uploads/2021/05/ASCO-ONLINE-Publication.png https://www.aexcea.com/revision-on-total-funding-secured-by-biomark-and-its-team-of-collaborators-on-chrp-application/ 2026-09-24T19:38:45+00:00 https://www.aexcea.com/biomark-announces-new-patent-granted-in-united-states/ 2026-09-24T19:38:44+00:00 https://www.aexcea.com/national-research-team-targets-glioblastoma/ 2026-09-24T19:38:43+00:00 https://www.aexcea.com/wp-content/uploads/2021/05/UoM-GBM-News.jpg https://www.aexcea.com/biomark-announces-debt-settlement/ 2026-09-24T19:38:42+00:00 https://www.aexcea.com/the-university-of-maryland-school-of-medicine-enters-research-collaboration-with-biomark-diagnostics/ 2026-09-24T19:38:41+00:00 https://www.aexcea.com/new-advances-in-liquid-biopsy-to-increase-biomarks-assay-performance/ 2026-09-24T19:38:40+00:00 https://www.aexcea.com/biomarks-liquid-biopsy-scientific-paper-to-be-featured-as-cover-on-cancers-upcoming-issue-2/ 2026-09-24T19:38:39+00:00 https://www.aexcea.com/biomarks-liquid-biopsy-scientific-paper-to-be-featured-as-cover-on-cancers-upcoming-issue/ 2026-09-24T19:38:38+00:00 https://www.aexcea.com/wp-content/uploads/2015/03/Cancer-Cover-e1566243667506.jpg https://www.aexcea.com/new-scientific-publication-further-supports-biomarks-assay/ 2026-09-24T19:38:37+00:00 https://www.aexcea.com/biomark-signs-letter-of-intent-for-licensing-relationship-for-clinical-validation-and-development/ 2026-09-24T19:38:36+00:00 https://www.aexcea.com/biomark-announces-private-placement/ 2026-09-24T19:38:35+00:00 https://www.aexcea.com/biomark-announces-private-placement-2/ 2026-09-24T19:38:33+00:00 https://www.aexcea.com/canadian-trade-commissioner-service-features-biomark-diagnostics-next-generation-cancer-diagnostics/ 2026-09-24T19:38:32+00:00 https://www.aexcea.com/biomark-closes-the-over-subscribed-private-placement-offering/ 2026-09-24T19:38:31+00:00 https://www.aexcea.com/biomark-diagnostics-reviews-2019-and-outlines-plans-for-2020/ 2026-09-24T19:38:30+00:00 https://www.aexcea.com/biomarks-scientific-advisor-named-dean-of-schulich-school-of-medicine-and-dentistry/ 2026-09-24T19:38:29+00:00 https://www.aexcea.com/biomarks-market-update-report/ 2026-09-24T19:38:28+00:00 https://www.aexcea.com/biomark-diagnostics-advanced-raman-spectrometer-could-potentially-serve-as-complementary-detection-tool-for-covid-19-coronavirus/ 2026-09-24T19:38:27+00:00 https://www.aexcea.com/who-outlines-steps-to-save-7-million-lives-from-cancer/ 2026-09-24T19:38:26+00:00 https://www.aexcea.com/biomarks-liquid-biopsy-assay-levering-metabolomics-demonstrates-strong-performance-for-early-lung-cancer-detection/ 2026-09-24T19:38:25+00:00 https://www.aexcea.com/dr-horacio-bach-one-of-biomarks-scientific-advisor-and-expert-on-antibody-engineering-received-a-major-grant-from-cihr-for-covid-19-antibody-development/ 2026-09-24T19:38:24+00:00 https://www.aexcea.com/wp-content/uploads/2021/05/IMG-20200331-WA0008.jpg https://www.aexcea.com/biomark-diagnostics-forms-new-company-bio-stream-diagnostics-inc-for-30-second-covid-19-screening/ 2026-09-24T19:38:23+00:00 https://www.aexcea.com/biomark-diagnostics-inc-clarifies-prior-disclosure/ 2026-09-24T19:38:22+00:00 https://www.aexcea.com/bio-stream-diagnostics-inc-selected-for-cdl-rapid-response-innovation-program/ 2026-09-24T19:38:21+00:00 https://www.aexcea.com/biomark-receives-european-patent-for-cancer-diagnostic/ 2026-09-24T19:38:20+00:00 https://www.aexcea.com/biomark-diagnostics-announces-peer-reviewed-publication-on-detection-of-cancer/ 2026-09-24T19:38:19+00:00 https://www.aexcea.com/biomark-diagnostics-inc-receives-full-registered-trademark-status-from-the-us-patent-and-trademark-office-for-its-company-brand-name-biomark/ 2026-09-24T19:38:18+00:00 https://www.aexcea.com/biomarks-affiliated-company-bio-stream-diagnostics-inc-announces-partnership-with-qatar-university-ml-team-for-development-of-covid-19-testing/ 2026-09-24T19:38:18+00:00 https://www.aexcea.com/biomark-diagnostics-expands-research-development-in-quebec/ 2026-09-24T19:38:17+00:00 https://www.aexcea.com/biomark-team-secures-health-canada-letter-of-no-objection-for-its-glioblastoma-clinical-trial/ 2026-09-24T19:38:16+00:00 https://www.aexcea.com/biomark-team-invited-for-full-application-for-sparks-grant-competition/ 2026-09-24T19:38:15+00:00 https://www.aexcea.com/biomark-appoints-dr-jean-francois-haince-as-strategic-advisor-to-guide-its-expansion-into-quebec/ 2026-09-24T19:38:13+00:00 https://www.aexcea.com/biomark-scientific-advisor-dr-donald-miller-to-present-at-the-delaware-valley-drug-metabolism-discussion-group/ 2026-09-24T19:38:12+00:00 https://www.aexcea.com/richmond-company-looking-for-holy-grail-in-covid-19-testing/ 2026-09-24T19:38:11+00:00 https://www.aexcea.com/wp-content/uploads/2020/10/biomark-diagnostics-holy-grail-covid-19.jpg https://www.aexcea.com/alfred-berkeley-joins-biomarks-advisory-team/ 2026-09-24T19:38:10+00:00 https://www.aexcea.com/biomark-retains-questrade-inc-to-provide-market-making-services/ 2026-09-24T19:38:09+00:00 https://www.aexcea.com/doctors-fear-an-impending-wave-of-cancer-patients-after-covid-19-delays/ 2026-09-24T19:38:08+00:00 https://www.aexcea.com/wp-content/uploads/2021/02/News-1130-logo.png https://www.aexcea.com/world-cancer-day-a-leading-international-awareness-day/ 2026-09-24T19:38:07+00:00 https://www.aexcea.com/biomark-diagnostics-targets-response-to-treatment-application-with-its-liquid-biopsy-platform/ 2026-09-24T19:38:06+00:00 https://www.aexcea.com/missing-cancer-cases-a-worrying-pandemic-trend/ 2026-09-24T19:38:05+00:00 https://www.aexcea.com/biomark-and-phytronix-technologies-inc-enter-into-a-collaborative-research-and-development-agreement/ 2026-09-24T19:38:04+00:00 https://www.aexcea.com/biomark-grants-options/ 2026-09-24T19:38:03+00:00 https://www.aexcea.com/cancer-that-went-undetected-during-the-pandemic-an-impending-disaster-specialists-warn/ 2026-09-24T19:38:02+00:00 https://www.aexcea.com/yearly-lung-cancer-scans-are-advised-for-people-50-and-over-with-shorter-smoking-histories/ 2026-09-24T19:38:01+00:00 https://www.aexcea.com/wp-content/uploads/2021/03/A-computed-tomography-scan-of-lungs-805x503-1.jpg https://www.aexcea.com/biomarks-collaborator-receives-funding-to-validate-its-biomarker-panel-for-the-early-detection-of-lung-cancer/ 2026-09-24T19:38:00+00:00 https://www.aexcea.com/u-of-alberta-researchers-win-120k-grant-to-develop-metabolite-based-lung-cancer-test/ 2026-09-24T19:37:59+00:00 https://www.aexcea.com/3-cancer-diagnostic-stocks-to-watch-following-roches-genmark-buy/ 2026-09-24T19:37:58+00:00 https://www.aexcea.com/long-time-cardiologist-dr-myron-weisfeldt-who-changed-face-of-hopkins-receiving-american-heart-associations-distinguished-watkins-saunders-award-for-commitment-to-overcomin/ 2026-09-24T19:37:57+00:00 https://www.aexcea.com/wp-content/uploads/2021/03/dr-mike-weisfeldt.png https://www.aexcea.com/wp-content/uploads/2021/03/Dr-Saunders.jpg https://www.aexcea.com/wp-content/uploads/2021/03/Dr-Watkins.jpg https://www.aexcea.com/a-simple-blood-test-to-detect-lung-cancer/ 2026-09-24T19:37:56+00:00 https://www.aexcea.com/wp-content/uploads/2021/03/dr-david-wishart.jpg https://www.aexcea.com/alberta-research-to-spot-early-stage-lung-cancer/ 2026-09-24T19:37:55+00:00 https://www.aexcea.com/wp-content/uploads/2021/04/david-wishart-genome-alberta-biomark-diagnostics.jpg https://www.aexcea.com/biomark-announces-exercise-of-warrants-and-gain-dtc-eligibility-for-its-common-shares/ 2026-09-24T19:37:54+00:00 https://www.aexcea.com/biomark-to-open-a-diagnostic-laboratory-in-quebec/ 2026-09-24T19:37:53+00:00 https://www.aexcea.com/wp-content/uploads/2021/05/Dr-Haince.jpg https://www.aexcea.com/biomark-diagnostics-and-phytronix-technologies-strategic-technology-integration-partnership/ 2026-09-24T19:37:52+00:00 https://www.aexcea.com/wp-content/uploads/2021/05/Dr-Haince.jpg https://www.aexcea.com/10-reasons-why-biomark-bux-is-a-buy-and-long-term-hold/ 2026-09-24T19:37:51+00:00 https://www.aexcea.com/liquid-biopsy-what-is-it/ 2026-09-24T19:37:50+00:00 https://www.aexcea.com/biomark-announces-change-of-auditor/ 2026-09-24T19:37:49+00:00 https://www.aexcea.com/biomark-recoit-une-subvention-de-825-k-pour-developper-son-test-de-biopsie-liquide-pour-le-depistage-du-cancer-du-poumon/ 2026-09-24T19:37:48+00:00 https://www.aexcea.com/biomark-receives-825k-grant-to-develop-its-liquid-biopsy-assay-for-lung-cancer-screening/ 2026-09-24T19:37:47+00:00 https://www.aexcea.com/biomark-to-expand-treatment-response-trial-to-advanced-lung-cancer-patient-receiving-immunotherapy/ 2026-09-24T19:37:46+00:00 https://www.aexcea.com/biomark-to-present-new-cancer-screening-data-using-the-ldtd-ms-ms-technique-at-the-annual-asms-conference-on-mass-spectrometry/ 2026-09-24T19:37:45+00:00 https://www.aexcea.com/press-release-biomark-announces-closing-of-15-million-financing-round-to-accelerate-commercialization-of-its-liquid-biopsy-technology/ 2026-09-24T19:37:44+00:00 https://www.aexcea.com/biotech-brothers-interview-with-rashid-ahmed-ceo-biomark-diagnostics/ 2026-09-24T19:37:43+00:00 https://www.aexcea.com/biomark-continues-to-strengthen-its-intellectual-property-position-with-new-patentand-trademark-use-in-canada/ 2026-09-24T19:37:41+00:00 https://www.aexcea.com/biomark-provides-financial-results-for-the-year-ended-march-31-2022-and-recent-corporate-highlights/ 2026-09-24T19:37:40+00:00 https://www.aexcea.com/biomark-provides-first-quarter-2022-financial-results-and-operational-update/ 2026-09-24T19:37:39+00:00 https://www.aexcea.com/biomark-selected-by-the-medical-alley-and-investissement-quebec-to-join-the-us-go-to-market-accelerator/ 2026-09-24T19:37:38+00:00 https://www.aexcea.com/biomark-to-present-validation-data-of-its-multianalyte-metabolite-panel-for-lung-cancer-screening-at-the-esmo-congress-2022/ 2026-09-24T19:37:36+00:00 https://www.aexcea.com/the-us-patent-office-grants-biomark-additional-patent-for-its-liquid-biopsy-technology/ 2026-09-24T19:37:35+00:00 https://www.aexcea.com/biomarks-glioblastoma-study-published-in-cancers-demonstrates-inhibiting-sat1-sensitized-cancer-cells-towards-radiation-and-chemotherapy/ 2026-09-24T19:37:34+00:00 https://www.aexcea.com/biomark-provides-business-update-and-second-quarter-financial-results/ 2026-09-24T19:37:33+00:00 https://www.aexcea.com/biomark-announces-update-from-ongoing-clinical-trial-using-its-lung-cancer-liquid-biospy-test-as-it-prepares-for-commercial-launch/ 2026-09-24T19:37:32+00:00 https://www.aexcea.com/biomark-receives-funding-support-research-and-development-project-for-cancer-treatment-monitoring/ 2026-09-24T19:37:31+00:00 https://www.aexcea.com/breaking-barriers-past-and-current-celebrating-the-legacy-of-dr-clarice-reid-pioneer-in-sickle-cell-research-biomark-diagnostics/ 2026-09-24T19:37:30+00:00 https://www.aexcea.com/wp-content/uploads/2023/02/dr-clarice-reid.jpg https://www.aexcea.com/wp-content/uploads/2023/02/prejudice-and-racism-dr-reid-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2023/02/systemic-barriers-and-discrimination-faced-by-black-women-in-science-and-medicine.jpg https://www.aexcea.com/wp-content/uploads/2023/02/diverisity-in-medicine-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2023/02/biomark-diagnostics-rashid-ahmen.jpg https://www.aexcea.com/revolutionizing-cancer-research-meet-dr-juliet-daniel-the-trailblazing-black-scientist-making-a-difference-in-the-lives-of-triple-negative-breast-cancer-tnbc-patients/ 2026-09-24T19:37:29+00:00 https://www.aexcea.com/wp-content/uploads/2023/02/breast-cancer-survival-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2023/02/dr-juliet-daniel-breast-cancer-research-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2023/02/diverisity-in-medicine-and-science-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2023/02/biomark-diagnostics-rashid-ahmen.jpg https://www.aexcea.com/biomark-provides-third-quarter-operational-update-and-2023/ 2026-09-24T19:37:28+00:00 https://www.aexcea.com/indigenous-innovator-dr-nadine-carons-quest-for-equity-in-cancer-care-and-research/ 2026-09-24T19:37:27+00:00 https://www.aexcea.com/wp-content/uploads/2023/02/black-history-month-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2023/02/dr-nadine-caron-indigenous-innovator.jpg https://www.aexcea.com/wp-content/uploads/2023/02/indigenous-peoples-biomark-diagnostics.jpg https://www.aexcea.com/wp-content/uploads/2023/02/diversity-in-advanced-medical-research.jpg https://www.aexcea.com/wp-content/uploads/2023/02/dr-nadine-caron-and-her-important-work-and-research.jpg https://www.aexcea.com/biomark-presents-novel-liquid-biopsy-data-in-pulmonary-neuroendocrine-tumors/ 2026-09-24T19:37:26+00:00 https://www.aexcea.com/press-release-biomark-latest-results-accepted-for-presentation-at-the-american-society-of-clinical-oncology-asco-annual-meeting-2023/ 2026-09-24T19:37:25+00:00 https://www.aexcea.com/biomark-announces-the-u-s-patent-and-trademark-office-granted-patent-with-claims-covering-its-lung-cancer-liquid-biopsy-assay/ 2026-09-24T19:37:24+00:00 https://www.aexcea.com/biomarks-dr-maksymuik-presents-at-prestigous-asco-annual-meeting/ 2026-09-24T19:37:23+00:00 https://www.aexcea.com/wp-content/uploads/2023/06/ASCO-1-1024x576.jpg https://www.aexcea.com/wp-content/uploads/2023/06/ASCO-3-Dr.-Maksymuik-1024x803.jpg https://www.aexcea.com/wp-content/uploads/2023/06/ASCO-2-1024x768.jpg https://www.aexcea.com/biomark-unveils-significant-scientific-advancements-from-its-leading-liquid-biopsy-technology-at-asco-2023-annual-meeting/ 2026-09-24T19:37:22+00:00 https://www.aexcea.com/biomark-issues-statement-on-recent-market-activity-and-provides-a-brief-corporate-update/ 2026-09-24T19:37:21+00:00